← Live Studies
ENLIGHTEN-1: Eloralintide for obesity without type 2 diabetes
Compares once-weekly investigational eloralintide with placebo in adults with obesity or overweight who do not have type 2 diabetes.
Who it's for
- Age 18+
- BMI ≥30, or ≥27 plus a weight-related condition
- People with type 2 diabetes excluded
Full eligibility rules apply. The study team decides who can take part.
Where it runs
9 research locations in Arizona, California and Hawaii.
Arizona
- Headlands Research - ScottsdaleScottsdale, AZ
California
- Neighborhood Healthcare Institute of HealthEscondido, CA
- Ark Clinical Research - Fountain ValleyFountain Valley, CA
- Desert Oasis Healthcare Medical GroupPalm Springs, CA
- Peninsula Research AssociatesRolling Hills Estates, CA
- Care Access - SacramentoSacramento, CA
- Southern California Clinical ResearchSanta Ana, CA
- University Clinical Investigators, Inc.Tustin, CA
Hawaii
- East-West Medical Research InstituteHonolulu, HI
Site recruitment may change. The official record lists every location, including outside these states.
Interested in this study?
Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

